Danbury News Times |
Boehringer Ingelheim's asthma drug wins FDA approval
Danbury News Times DANBURY — Nearly one in 10 adults in Connecticut – 9.2 percent – has asthma. Boehringer Ingelheim, the Danbury-based pharmaceutical company cited the figure as it announced the federally approved availability of its new Spiriva Respimat product for … Spiriva Respimat Now Available in Pharmacies for Asthma Patients |
View full post on asthma – Google News